<DOC>
	<DOCNO>NCT01511705</DOCNO>
	<brief_summary>This open label , balance , randomize , two-treatment , two-period , two sequence , single dose , crossover , oral bioequivalence study .</brief_summary>
	<brief_title>Bioequivalence Study Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition</brief_title>
	<detailed_description>The study open label , balance , randomize , two-treatment , two-period , two sequence , single dose , crossover , oral bioequivalence study Ondansetron Hydrochloride tablets 8 mg Dr. Reddy 's Laboratories Limited , India compare Zofran® ( contain Ondansetron Hydrochloride Dihydrate ) tablets 8 mg GlaxoSmithKline , USA healthy , adult , human subject fast condition . 26 subject enrol study , 24 subject complete study .</detailed_description>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Subjects provide write informed consent . Subjects healthy adult within 18 45 year age ( inclusive ) . Body mass index ≥ 18 kg/m2 ≤ 25 kg/m2 , body weight less 50 kg . Subjects normal health determine medical history physical examination perform within 15 day prior dose period I . Had normal ECG , Chest Xray vital sign Availability subject entire study period willingness adhere protocol requirement evidence write informed consent . If subject female volunteer child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . postmenopausal least 1 year surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) Each female subject suppose undergo urine pregnancy test checkin periodI , periodII post study . Subjects incapable understanding informed consent . Subjects BP ≤ 9060 mm/Hg BP ≥ 140/90 mm/Hg . History hypersensitivity idiosyncratic reaction ondansetron relate drug . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . Subjects history tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . Regular smoker smoke ten cigarette daily difficulty abstain smoke duration study period . Subjects take counter prescribed medication , include enzyme modifying drug systemic medication past 30 day prior dose PeriodI . History psychiatric illness , may impair ability provide write informed consent . Subjects history alcohol substance abuse within last 5 year . Subjects clinically significant abnormal value laboratory parameter . Subjects participate clinical investigation use experimental drug bleed 350 mL past 3 month . Subjects unable likely noncomplaint protocol requirement restriction . Any subject ondansetron contraindicate medical reason . Subjects intolerant venipuncture . Subjects positive urine screen drug abuse . All subject urine sample assay presence drug abuse study period checkin . Subjects found urine concentration test drug allow participate . Female volunteer use implant injected hormonal contraceptive anytime 6 month prior study use hormonal contraceptive 14 day dose . Female volunteer negative pregnancy test All female subject screen pregnancy check study period . Subjects positive inconclusive result withdrawn study . Female volunteer currently breast feed . Female subject pregnant , breastfeeding , likely become pregnant study allow participate . Female subject child bear potential must either abstain form sexual intercourse use reliable barrier method ( e.g condom , IUD ) contraception course study ( first dose last blood collection ) allow participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Ondansetron</keyword>
	<keyword>crossover</keyword>
</DOC>